Julianna Pherarolis

Julianna Pherarolis

25 Jun, 2025

“I am incredibly satisfied with the work Celegence has done thus far. They communicate well and receive feedback well. I find the team I have been assigned incredibly easy to work with, friendly, and people I genuinely look forward to speaking with once a week.”

Other Related Articles

Beyond Implementation: Why Many RIM Programs Fail to Deliver Business Value

Blog Pharmaceutical

Beyond Implementation: Why Many RIM Programs Fail to Deliver Business Value

25 Aug, 2026

The Most Expensive Mistakes in Biotech Are Often Regulatory, Not Scientific

Blog Pharmaceutical

The Most Expensive Mistakes in Biotech Are Often Regulatory, Not Scientific

20 Aug, 2026

Optimizing Systematic Literature Reviews for CERs: Common Deficiencies and How to Avoid Them

Blog Medical Devices

Optimizing Systematic Literature Reviews for CERs: Common Deficiencies and How to Avoid Them

20 Aug, 2026

M4Q(R2) Transition Readiness: Migrating CMC Content for the Structured Submissions of Tomorrow

Blog Pharmaceutical

M4Q(R2) Transition Readiness: Migrating CMC Content for the Structured Submissions of Tomorrow

19 Aug, 2026

Notified Body Opinion (NBOp) for Combination Products: Navigating Article 117 of the EU MDR

Blog Medical Devices

Notified Body Opinion (NBOp) for Combination Products: Navigating Article 117 of the EU MDR

19 Aug, 2026

Received a Notified Body Deficiency Letter for Your CER? Here’s What to Do Next

Blog Medical Devices

Received a Notified Body Deficiency Letter for Your CER? Here’s What to Do Next

13 Aug, 2026

Are Your CERs Audit Ready? 10 Warning Signs Before Your Next Notified Body Review

Blog Medical Devices

Are Your CERs Audit Ready? 10 Warning Signs Before Your Next Notified Body Review

13 Aug, 2026

Technology Transfer in Pharma: Best Practices for Successful CMC and Regulatory Compliance

Blog Pharmaceutical

Technology Transfer in Pharma: Best Practices for Successful CMC and Regulatory Compliance

06 Aug, 2026

View All